Paul Brannelly Insider Profile
4 Followers
Paul Brannelly, EVP & CFO at Collegium Pharmaceutical, holds 215.43K shares in Collegium Pharmaceutical (Ticker: COLL), holds 66.14K shares in Karyopharm Therapeutics (Ticker: KPTIQ).
Paul Brannelly's Trading History
You May Also Like
Paul Brannelly insider profile FAQ
What is the percentage of profitable transactions made by Paul Brannelly?
The percentage of profitable transactions made by Paul Brannelly is 75%.
What is the average return per transaction made by Paul Brannelly?
The average return per transaction made by Paul Brannelly is 45.90%.
What stocks does Paul Brannelly hold?
Paul Brannelly holds: COLL, KPTIQ stocks.
What was Paul Brannelly’s latest transaction?
Paul Brannelly’s latest transaction was an Uninformative Sell of $220.34K.
What was Paul Brannelly's most profitable transaction?
Paul Brannelly’s most profitable transaction was an Informative Buy of COLL stock on May 15, 2017. The return on the trade was 176.60%.
What is Paul Brannelly's role in Collegium Pharmaceutical?
Paul Brannelly's role in Collegium Pharmaceutical is EVP & CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
